Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Income from Continuing Operations (2016 - 2025)

Palisade Bio has reported Income from Continuing Operations over the past 16 years, most recently at 9983000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations fell 194.92% to 9983000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18066000.0 through Dec 2025, down 21.48% year-over-year, with the annual reading at 18066000.0 for FY2025, 21.48% down from the prior year.
  • Income from Continuing Operations was 9983000.0 for Q4 2025 at Palisade Bio, down from 2927000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 2311000.0 in Q1 2025 and troughed at 33513000.0 in Q2 2021.
  • The 5-year median for Income from Continuing Operations is 3612000.0 (2023), against an average of 5366951.74.
  • Year-over-year, Income from Continuing Operations plummeted 1718.88% in 2021 and then skyrocketed 89.33% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 3042000.0 in 2021, then fell by 26.59% to 3851000.0 in 2022, then grew by 18.0% to 3158000.0 in 2023, then dropped by 7.19% to 3385000.0 in 2024, then crashed by 194.92% to 9983000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Income from Continuing Operations are 9983000.0 (Q4 2025), 2927000.0 (Q3 2025), and 2845000.0 (Q2 2025).